Evidence map›Paper›PMID 41640891›Full record

ArticleCureus2026

Population Screening for Diabetes and Prediabetes in North Macedonia and Bosnia and Herzegovina: A Transnational Epidemiological Report.

Tatjana Milenkovic, Zelija Velija Asimi, Ivica Smokovski, Nadica Bozhinovska Dimova, Azra Burekovic

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatjana MilenkovicEndocrinology, Diabetes and Metabolism, University Clinic of Endocrinology, Diabetes and Metabolic Diseases, Faculty of Medical Sciences, University St. Cyril and Methodius, Skopje, MKD.
Zelija Velija AsimiEndocrinology and Diabetes, SSST University (Sarajevo School of Science and Technology University), Sarajevo, BIH.
Ivica SmokovskiFaculty of Medical Sciences, University Goce Delcev, Stip, MKD.
Nadica Bozhinovska DimovaEndocrinology, Diabetes and Metabolism, Clinical Hospital Acibadem Sistina, Skopje, MKD.
Azra BurekovicEndocrinology, Diabetes and Metabolism, University Clinical Hospital for Endocrinology, Diabetes and Metabolic Diseases, Sarajevo, BIH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While North Macedonia (NM) and Bosnia and Herzegovina (BH) have a relatively high prevalence of diabetes, both countries have a low diagnostic rate due to the lack of unified eHealth systems. We conducted a small-scale, general screening epidemiologic study in NM and BH for a better understanding of the high prevalence of diabetes in our region. A total of 1,291 individuals at risk of diabetes were studied. The diagnostic criteria for diabetes included fasting plasma glucose (FPG) ≥7.0 mmol/L or glycated hemoglobin (HbA1c) ≥6.5%, while prediabetes was diagnosed using impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). The prevalence of diabetes and prediabetes was higher in NM, with a combined rate of 78% compared to 71% in BH. After adjusting for gender, smoking, waist circumference, and triglycerides, the NM group is 1.45 times at greater risk for diabetes. General population screening for diabetes and prediabetes can serve as a cost-effective approach to address the escalating diabetes burden in the Western Balkans. Collaborative initiatives to enhance the integration of national health systems, ensure data reliability, and prioritize preventive healthcare are essential for achieving sustainable diabetes management.

Indexed as

health system researchpre-diabetesprevalence of diabetesscreeningtype 2 diabetes mellitus

Identifiers

PMID41640891
PMCPMC12865874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.